Cargando…
Reduced Dose Intensities of Doxorubicin in Elderly Patients with DLBCL in Rituximab Era
PURPOSE: The dose intensity of doxorubicin (DID) is important to the survival of diffuse large B cell lymphoma (DLBCL) patients. However, due to expected toxicities, most elderly patients cannot receive full doses of anthracyclines. The purpose of this study was to evaluate the effect of DID on the...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720063/ https://www.ncbi.nlm.nih.gov/pubmed/25865654 http://dx.doi.org/10.4143/crt.2014.339 |